Sign in to continue:

Wednesday, February 4th, 2026

Infinity Development Holdings IPO

Infinity Development Holdings is conducting an all-placement IPO on the Singapore Exchange’s (SGX) Catalist board, with trading set to begin on December 3, 2025. The Hong Kong-based adhesives manufacturer aims to raise S$11.1 million in net proceeds by issuing 35.1 million shares at S$0.39 each. This IPO is part of a strategic expansion effort and was preceded by a share consolidation on its existing Hong Kong-listed stock.

IPO details and financial context

Listing Venue and Date: Infinity Development will list on the SGX Catalist board on December 3, 2025, complementing its existing Hong Kong listing (HKG:640).

Fundraising: The company intends to raise S$11.1 million in net proceeds, or S$13.7 million in gross proceeds, via an all-placement of 35.1 million shares.

Valuation: The IPO is priced at a historical FY2024 P/E ratio of 7.2 times, based on an EPS of 5.4 cents in FY2024. The placement price of S$0.39 per share implies a market capitalization of S$123.5 million.

Use of Proceeds: The funds will be allocated as follows:

S$6.2 million for overseas expansion in markets like India.

S$2.4 million for potential acquisitions, joint ventures, or strategic alliances.

S$2.4 million for general working capital.

Placement Structure: The shares are being placed with a minimum of 200 independent investors. The placement is not underwritten.

Business and market outlook

Growth Prospects: Infinity Development sees strong growth in the Asian footwear adhesives market, with projections of a 4.5% to 5.5% compound annual growth rate over the next five years.

Market Position: The company positions itself as a leading footwear adhesive supplier in Asia, with operations in 10 locations and 400 employees.

Customer Concentration: A major risk is the company’s reliance on a few large customers. Its top five customers contributed over 30% of its revenue between FY2022 and H1 FY2025.

Geopolitical Risks: The company notes its exposure to geopolitical risks, such as tariffs.

Operational Details: Customers place orders “from time to time,” as the company does not have long-term contracts.

Share consolidation prior to the IPO

Purpose: To meet the minimum issue price requirement for its SGX listing, the company performed a share consolidation on its existing Hong Kong shares on a 2-for-1 basis.

Timeline: The share consolidation took effect on October 20, 2025, with trading of the consolidated shares commencing on November 4, 2025.

Impact: This reduced the number of shares and increased the share price per lot, which also changed from 4,000 to 2,000 shares.

Key Performance Indicators & Positive Aspects

Strong Financial Growth: The company has demonstrated robust earnings per share (EPS) growth, with a 34% per year increase over the last three years. In the first half of FY2025, net profit rose 38% year-on-year.

Consistent Dividends: The company pays a dividend and has an attractive yield (around 8.2%). Dividends have notably boosted the total shareholder return (TSR).

Market Position & Strategy: Infinity Development is a leading adhesives manufacturer in Asia, aiming for further expansion in India and Indonesia to capture a growing market for eco-friendly, high-performance adhesives.

Insider Confidence: Insiders hold a significant majority (75%) of the company’s stock, suggesting strong alignment between management and company performance.

Analyst Sentiment: At least one analyst has given a “Buy” rating with a price target above the current trading price.

Potential Risks & Concerns

Customer Concentration Risk: A significant portion of revenue comes from a handful of major customers (top five customers contributed about 44% of revenue in some periods), meaning the loss of any major contract could impact financials.

Market Competition & Raw Material Costs: The company operates in a highly competitive market and is exposed to fluctuations in raw material costs and currency risks.

Geopolitical Risks: The company is exposed to geopolitical risks, such as potential tariffs imposed by countries like the United States.

Lack of Long-Term Contracts: The company notes it does not have long-term contracts with customers, who place orders “from time to time”.

Thank you

Singapore Post’s Strategic Transformation: Unlocking $2.5 Billion in Assets by 2027

Singapore Post and Global Logistics Companies: A Comprehensive Financial Analysis Singapore Post and Global Logistics Companies: A Comprehensive Financial Analysis Date: November 6, 2024 Broker: CGS International Securities Singapore Post Ltd: Awaiting Value Unlocking...

Sembcorp Industries: Wind of Change – Shifting Focus from Sustainable Solutions Amid Energy Transition

Sembcorp Industries: Comprehensive Financial Analysis and Investment Insights Sembcorp Industries: Comprehensive Financial Analysis and Investment Insights Date: February 4, 2025 Broker: Maybank Research Pte Ltd Introduction to Sembcorp Industries Sembcorp Industries (SCI) is a...

Hanx Biotech IPO Prospectus 2025: Innovative Cancer & Autoimmune Drug Pipeline, Key Products HX009, HX301, HX044, Investment Highlights & Market Opportunities

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. IPO Analysis – December 15, 2025 Hanx Biopharmaceuticals (Wuhan) Co., Ltd. Date of prospectus: December 15, 2025 Hanx Biopharmaceuticals Pre-Revenue Biotech IPO: In-Depth Investor Analysis, Offer Structure, and Listing...